.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Argus Health
Chubb
Mallinckrodt
Chinese Patent Office
Fuji
Baxter
AstraZeneca
Julphar
Fish and Richardson

Generated: February 24, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: riboflavin 5\'-phosphate sodium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Avedro IncPHOTREXAriboflavin 5'-phosphate sodiumSOLUTION/DROPS;OPHTHALMIC203324NDAAvedro, Inc.N25357-022-01
Avedro IncPHOTREXAriboflavin 5'-phosphate sodiumSOLUTION/DROPS;OPHTHALMIC203324NDAAvedro, Inc.N25357-023-01
Avedro IncPHOTREXAriboflavin 5'-phosphate sodiumSOLUTION/DROPS;OPHTHALMIC203324NDAAvedro, Inc.N25357-025-03
Avedro IncPHOTREXA VISCOUS IN DEXTRAN 20%riboflavin 5'-phosphate sodiumSOLUTION/DROPS;OPHTHALMIC203324NDAAvedro, Inc.N25357-022-01
Avedro IncPHOTREXA VISCOUS IN DEXTRAN 20%riboflavin 5'-phosphate sodiumSOLUTION/DROPS;OPHTHALMIC203324NDAAvedro, Inc.N25357-023-01
Avedro IncPHOTREXA VISCOUS IN DEXTRAN 20%riboflavin 5'-phosphate sodiumSOLUTION/DROPS;OPHTHALMIC203324NDAAvedro, Inc.N25357-025-03
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Fuji
Chinese Patent Office
US Army
Federal Trade Commission
Covington
Novartis
UBS
QuintilesIMS

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot